Tulosta

Lisätietoa ihon bakteeri-infektioista atooppisessa ekseemassa

Lisätietoa aiheesta
25.5.2016
Sanna Poikonen

Kirjallisuutta

  1. Lübbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol 2003;4:641-54 «PMID: 12926982»PubMed
  2. Williams RE, Gibson AG, Aitchison TC ym. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990;123:493-501 «PMID: 2095181»PubMed
  3. Nishijima S, Namura S, Kawai S ym. Staphylococcus aureus on hand surface and nasal carriage in patients with atopic dermatitis. J Am Acad Dermatol 1995;32:677-9 «PMID: 7896966»PubMed
  4. Breuer K, Haussler S, Kapp A ym. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002;147:55-61 «PMID: 12100185»PubMed
  5. Leung DY, Travers JB, Norris DA. The role of superantigens in skin disease. J Invest Dermatol 1995;105:37S-42S «PMID: 7615995»PubMed
  6. Hauk PJ, Leung DY. Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol 2001;107:391-2 «PMID: 11174211»PubMed
  7. Ong PY, Ohtake T, Brandt C ym. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60 «PMID: 12374875»PubMed
  8. Nomura I, Goleva E, Howell MD ym. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-9 «PMID: 12960356»PubMed
  9. Rieg S, Steffen H, Seeber S ym. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 2005;174:8003-10 «PMID: 15944307»PubMed
  10. Shah M, Mohanraj M. High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients. Br J Dermatol 2003;148:1018-20 «PMID: 12786835»PubMed
  11. Ravenscroft JC, Layton AM, Eady EA ym. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 2003;148:1010-7 «PMID: 12786834»PubMed
  12. Peeters KA, Mascini EM, Sanders CJ. Resistance of Staphylococcus aureus to fusidic acid. Int J Dermatol 2004;43:235-6 «PMID: 15009402»PubMed
  13. Hofer MF, Harbeck RJ, Schlievert PM ym. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999;112:171-6 «PMID: 9989792»PubMed
  14. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC ym. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 2010;163:12-26 «PMID: 20222931»PubMed